Dr. Gerard S. Goh and Dr. Thodur Vasudevan of the Alfred Hospital in Melbourne, Australia, completed the stent implant. The company says it introduces a “revolutionary advancement” in the mechanics, durability and drug delivery of peripheral drug-eluting stents.

Tel Aviv, Israel-based Medinol designed ChampioNIR to improve both patient outcomes and procedural success. It features a first-of-its-kind hybrid mechanical design with a self-expanding nitinol radial structure that provides flexibility and fracture resistance. A bioresorbable polymeric mesh provides a longitudinal structure for flexibility and durability in challenging anatomies.